Carregant...
Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody
AIM: To study whether adalimumab (ADA) was associated with improvement in growth, bone mineral density (BMD) and bone metabolism. METHODS: In children with Crohn’s disease (CD) there is a high prevalence of growth failure and reduced BMD. Treatment with infliximab is associated with an improvement i...
Guardat en:
| Publicat a: | World J Gastroenterol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4458771/ https://ncbi.nlm.nih.gov/pubmed/26074699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i21.6613 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|